BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35640156)

  • 1. Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).
    Jefri M; Zhang X; Stumpf PS; Zhang L; Peng H; Hettige N; Theroux JF; Aouabed Z; Wilson K; Deshmukh S; Antonyan L; Ni A; Alsuwaidi S; Zhang Y; Jabado N; Garcia BA; Schuppert A; Bjornsson HT; Ernst C
    Hum Mol Genet; 2022 Oct; 31(21):3715-3728. PubMed ID: 35640156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
    Schwenty-Lara J; Nehl D; Borchers A
    Hum Mol Genet; 2020 Jan; 29(2):305-319. PubMed ID: 31813957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of function of Kmt2d, a gene mutated in Kabuki syndrome, affects heart development in Xenopus laevis.
    Schwenty-Lara J; Nürnberger A; Borchers A
    Dev Dyn; 2019 Jun; 248(6):465-476. PubMed ID: 30980591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.
    Wang C; Lee JE; Lai B; Macfarlan TS; Xu S; Zhuang L; Liu C; Peng W; Ge K
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11871-11876. PubMed ID: 27698142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
    Carosso GA; Boukas L; Augustin JJ; Nguyen HN; Winer BL; Cannon GH; Robertson JD; Zhang L; Hansen KD; Goff LA; Bjornsson HT
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31465303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.
    Ang SY; Uebersohn A; Spencer CI; Huang Y; Lee JE; Ge K; Bruneau BG
    Development; 2016 Mar; 143(5):810-21. PubMed ID: 26932671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.
    Shpargel KB; Mangini CL; Xie G; Ge K; Magnuson T
    Development; 2020 Jul; 147(21):. PubMed ID: 32541010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.
    Fahrner JA; Lin WY; Riddle RC; Boukas L; DeLeon VB; Chopra S; Lad SE; Luperchio TR; Hansen KD; Bjornsson HT
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31557133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.
    Lee JE; Wang C; Xu S; Cho YW; Wang L; Feng X; Baldridge A; Sartorelli V; Zhuang L; Peng W; Ge K
    Elife; 2013 Dec; 2():e01503. PubMed ID: 24368734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of MLL4/COMPASS induce cytoplasmic localization providing molecular insight into cancer prognosis and treatment.
    Zhao Z; Aoi Y; Philips CN; Meghani KA; Gold SR; Yu Y; John LS; Qian J; Zeidner JM; Meeks JJ; Shilatifard A
    Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2310063120. PubMed ID: 38113256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.
    Wright A; Hall A; Daly T; Fontelonga T; Potter S; Schafer C; Lindsley A; Hung C; Bodamer O; Gussoni E
    FASEB J; 2021 Nov; 35(11):e21955. PubMed ID: 34613626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
    Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
    Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration.
    Pacelli C; Adipietro I; Malerba N; Squeo GM; Piccoli C; Amoresano A; Pinto G; Pucci P; Lee JE; Ge K; Capitanio N; Merla G
    Cells; 2020 Jul; 9(7):. PubMed ID: 32668765
    [No Abstract]   [Full Text] [Related]  

  • 15. H3K4 Methyltransferase Activity Is Required for MLL4 Protein Stability.
    Jang Y; Wang C; Zhuang L; Liu C; Ge K
    J Mol Biol; 2017 Jun; 429(13):2046-2054. PubMed ID: 28013028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome.
    Pilarowski GO; Cazares T; Zhang L; Benjamin JS; Liu K; Jagannathan S; Mousa N; Kasten J; Barski A; Lindsley AW; Bjornsson HT
    J Allergy Clin Immunol; 2020 Mar; 145(3):982-992. PubMed ID: 31816409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
    Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
    Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.
    Lindsley AW; Saal HM; Burrow TA; Hopkin RJ; Shchelochkov O; Khandelwal P; Xie C; Bleesing J; Filipovich L; Risma K; Assa'ad AH; Roehrs PA; Bernstein JA
    J Allergy Clin Immunol; 2016 Jan; 137(1):179-187.e10. PubMed ID: 26194542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities.
    Sobreira N; Brucato M; Zhang L; Ladd-Acosta C; Ongaco C; Romm J; Doheny KF; Mingroni-Netto RC; Bertola D; Kim CA; Perez AB; Melaragno MI; Valle D; Meloni VA; Bjornsson HT
    Eur J Hum Genet; 2017 Dec; 25(12):1335-1344. PubMed ID: 29255178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape.
    Wang LH; Aberin MAE; Wu S; Wang SP
    Biochem Soc Trans; 2021 Jun; 49(3):1041-1054. PubMed ID: 34156443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.